SE

SEQUENOM INC

  • CIK: 0001076481
  • EIN: 77-0365889
  • Business address: 3595 JOHN HOPKINS COURT, SAN DIEGO, X1, 92121

Information

  • Mailing address
    3595 JOHN HOPKINS COURT, SAN DIEGO, Delaware, 92121
  • Phone
    8582029000
  • State location
    X1
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    3829 - (CF Office: Office of Life Sciences) MEASURING & CONTROLLING DEVICES, NEC
  • Filings
    N/A

About SEQUENOM INC

SEQUENOM INC (CIK: 0001076481) is an American company incorporated in the state of X1. Head office is located at 3595 JOHN HOPKINS COURT, SAN DIEGO, X1, 92121. Work in the industry 3829 - (CF Office: Office of Life Sciences) MEASURING & CONTROLLING DEVICES, NEC. SEQUENOM INC is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
LABORATORY CORP OF AMERICA HOLDINGS 0000920148 Sep-07-2016 10 percent owner
EISENBERG GLENN A 0001222831 Sep-07-2016 director, officer: EVP and Treasurer
EBERTS F SAMUEL III 0001229291 Sep-07-2016 director, officer: Chairman, President & Sec
HAAS WILLIAM 0001275833 Sep-07-2016 director
Miller Benjamin R 0001327701 Sep-07-2016 director
van der Vaart Sandra D 0001537208 Sep-07-2016 director
LOZUK ROBERT 0001662459 Jan-26-2016 officer: SVP, Commercial Ops
MACKEY CATHERINE J 0001645330 Jan-04-2016 director
Camber Capital Management LLC 0001444043 Oct-01-2015 10 percent owner
GROSU DANIEL S MD 0001637487 May-01-2015 officer: SVP & CMO
LINTON JEFFREY D 0001193614 Sep-10-2014 officer: Sr VP & General Counsel
BOWEN R WILLIAM 0001230048 Feb-01-2014 officer: Sr. VP and General Counsel
WELCH WILLIAM J 0001237522 Feb-01-2014 officer: President & COO
BEAVER CAROLYN 0001335581 Feb-01-2014 officer: VP and Chief Accounting Ofcr
MONKO ALEXANDER MICHAEL 0001373222 Feb-01-2014 officer: Sr. VP, Genetic Analysis
BOMBARD ALLAN 0001454522 Feb-01-2014 officer: Chief Medical Officer
VAN DEN BOOM DIRK 0001498278 Feb-01-2014 officer: EVP & Chief Tech Ofcr
WEINER ROBIN 0001501726 Feb-01-2014 officer: Sr. VP, Reg Affairs & Quality
LAI GOLDMAN MYLA 0001168581 Sep-11-2012 director
PENDARVIS DAVID 0001196723 Jun-15-2011 director
SLACIK CHARLES P 0001204660 Jun-15-2011 director
FAZIO JOHN A 0001234381 Jun-15-2011 director
BUECHLER KENNETH F 0001238916 Jun-15-2011 director
LERNER RICHARD A 0001316274 Jun-15-2011 director
MYRES LARRY 0001387409 Jun-15-2011 officer: VP, Operations
ZIMMERMAN JOSEPH 0001492916 Aug-03-2010 officer: VP & General Manager, SCMM
MAIER PAUL V 0001182615 Jul-20-2010 officer: Chief Financial Officer
MARCELL SHAWN M 0001474935 Oct-21-2009 officer: VP, Molecular Diag, Oncol
JUDGE ALISA 0001474936 Oct-21-2009 officer: VP Human Resources
FILE JUSTIN J 0001474649 Sep-28-2009 officer: Principal Acctg & Fncl Ofcr
Schmidt Karsten 0001321488 Jan-16-2009 officer: VP, Business Development
TATMAN DERECK 0001387408 Jan-16-2009 officer: VP, Business Development
OWINGS STEVE 0001387530 Jan-16-2009 officer: VP Ops, Prenatal Diagnostics
RIORDAN GARY 0001444932 Jan-16-2009 officer: VP, Reg Affairs & Quality
Ridgeback Capital Management LLC 0001357610 Jun-26-2008 10 percent owner
Ridgeback Capital Investments Ltd. 0001358916 Jun-26-2008 10 percent owner
Ridgeback Capital Investments L.P. 0001423994 Jun-26-2008 10 percent owner
ALDRICH RICHARD 0001185039 Jun-06-2008 10 percent owner
RA Capital Biotech Fund LP 0001315082 Jun-06-2008 10 percent owner
RA CAPITAL MANAGEMENT, LLC 0001346824 Jun-06-2008 10 percent owner
Kolchinsky Peter 0001384859 Jun-06-2008 10 percent owner
RA Capital Biotech Fund II, L.P. 0001392402 Jun-06-2008 10 percent owner
HAWRAN PAUL W 0001123344 Feb-26-2008 officer: Chief Financial Officer
Wiltsey Kathleen M 0001391408 Jun-25-2007 director
ENRIGHT PATRICK G 0001253886 Dec-07-2006 director
ComVest Group Holdings, LLC 0001373592 Dec-07-2006 10 percent owner
LEHMAN BROTHERS HOLDINGS INC 0000806085 Jun-06-2006 10 percent owner
LENIG LARRY E JR 0001207035 Jun-06-2006 director
Neumann Clarke 0001321466 Jun-06-2006 officer: VP and General Counsel
Stylli Harry 0001329344 Jun-06-2006 director, officer: President and CEO
Sharp John P 0001342894 Jun-06-2006 officer: VP Finance
SIEMENS AKTIENGESELLSCHAFT 0001135644 May-31-2006 10 percent owner
Siemens Venture Capital GmbH 0001365499 May-31-2006 10 percent owner
Dragon Elizabeth 0001362937 May-15-2006 officer: Sr. VP, Research & Development
PRIDDY ROBERT L 0000923232 Mar-27-2006 10 percent owner
FALK MICHAEL 0001014026 Mar-27-2006 10 percent owner
PEQUOT CAPITAL MANAGEMENT INC 0001071955 Mar-27-2006 other: See Footnote 1
COMMONWEALTH ASSOCIATES LP 0001119681 Mar-27-2006 10 percent owner
COMVEST INVESTMENT PARTNERS II LLC 0001275683 Mar-27-2006 10 percent owner
MOREAU LAWRENCE R 0001263115 Oct-25-2005 director
KISNER DANIEL L 0001073407 May-14-2004 director
HIXSON HARRY F JR 0001207600 May-14-2004 director
AFTING ERNST-GUNTER 0001234864 May-14-2004 director
LINDSAY RONALD M 0001241032 May-14-2004 director
LICHTER JAY B 0001234875 Apr-16-2004 officer: EVP Business Development
TERRY MICHAEL J 0001234885 Apr-16-2004 officer: EVP, Sales and Marketing
BRAUN ANDREAS 0001234867 Oct-28-2003 officer: Chief Medical Officer
CANTOR CHARLES R 0001234869 Oct-28-2003 director, officer: Chief Scientific Officer
LUCASJOHN 0001234876 Oct-28-2003 director
SCHUH ANTONIUS 0001234883 Oct-28-2003 director, officer: President and CEO
ZANIBONI STEVE 0001234887 Oct-28-2003 officer: SVP, CFO
MACDONALD RICHARD 0001234882 Jul-30-2003 officer: EVP, Bioinformatics and IT
NESTOR JOHN J 0001241035 Jul-17-2003 officer: EVP, Drug Discovery

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SEQUENOM INC

Filings Format Description Filed/Effective File/Film Number
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001306923-17-000010 (34 Act) Size: 41 KB		 Jan-12-2017

005-60383

17525994
15-12G Document

Notice of termination of registration of a class of securities under Section 12(g)

Acc-no: 0001193125-16-718028 (34 Act) Size: 9 KB		 Sep-23-2016

000-29101

161898950
EFFECT Document Acc-no: 9999999995-16-005746 (33 Act) Size: 1 KB Sep-22-2016

333-147146

161898603
EFFECT Document Acc-no: 9999999995-16-005745 (33 Act) Size: 1 KB Sep-22-2016

333-135015

161898604
EFFECT Document Acc-no: 9999999995-16-005748 (33 Act) Size: 1 KB Sep-22-2016

333-206655

161898591
EFFECT Document Acc-no: 9999999995-16-005747 (33 Act) Size: 1 KB Sep-22-2016

333-167061

161898599
CT ORDER Document Acc-no: 9999999997-16-025916 (34 Act) Size: 14 KB Sep-21-2016

000-29101

161895115
POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0001193125-16-710861 (33 Act) Size: 22 KB		 Sep-15-2016

333-206655

161887032
POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0001193125-16-710852 (33 Act) Size: 22 KB		 Sep-15-2016

333-147146

161887028
POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0001193125-16-710849 (33 Act) Size: 22 KB		 Sep-15-2016

333-167061

161887020
POS AM Document

Post-effective amendment to a registration statement that is not immediately effective upon filing

Acc-no: 0001193125-16-710847 (33 Act) Size: 22 KB		 Sep-15-2016

333-135015

161887016
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-16-710841 (33 Act) Size: 33 KB		 Sep-15-2016

333-67332

161887002
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-16-710840 (33 Act) Size: 33 KB		 Sep-15-2016

333-90778

161886999
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-16-710837 (33 Act) Size: 33 KB		 Sep-15-2016

333-99629

161886991
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-16-710834 (33 Act) Size: 33 KB		 Sep-15-2016

333-102769

161886988
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-16-710833 (33 Act) Size: 33 KB		 Sep-15-2016

333-112322

161886977
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-16-710829 (33 Act) Size: 33 KB		 Sep-15-2016

333-125456

161886975
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-16-710826 (33 Act) Size: 33 KB		 Sep-15-2016

333-134906

161886969
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-16-710819 (33 Act) Size: 33 KB		 Sep-15-2016

333-152230

161886957
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001193125-16-710815 (33 Act) Size: 33 KB		 Sep-15-2016

333-167831

161886952

Recent 20 filings. View all SEQUENOM INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Frequently Asked Questions

Tags:

  • SEQUENOM INC overview
  • SEQUENOM INC job
  • SEQUENOM INC stock
  • SEQUENOM INC ownership
  • SEQUENOM INC CEO
  • SEQUENOM INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

DIAMIR BIOSCIENCES CORP.
Update: Jun 29, 2024
ZONIC CORP
Update: Aug 26, 2022
ZOBRIST GERALD J
Update: Aug 26, 2022
XENOGEN CORP
Update: Aug 25, 2022
WHITE DAVID INC
Update: Aug 25, 2022
TRIMBLE INC.
Update: Aug 23, 2022

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 3132 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 1148 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 2930 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 1463 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 2732 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 1487 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 3039 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 1518 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 3128 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by